レナプロ L-FABP テスト TMB 添付文書
Contents
1. 0 05 37C 72 2 1 1000ppm 1 121C 20 2 8C 12 96 x1 1 Veerkamp JH and Maatman RG Prog Lipid Res 34 17 52 1995 2 33 24 27 2001 3 51 219 224 2003 4 Kamijo A et al J Lab Chn Med 143 23 30 2004 5 Kamijo A et al Am J Pathol 165 1243 1255 2004 6 Kamijo A et al J Lab Chn Med 145 125 133 2005 7 Nakamura T et al Diabetes Care 28 2728 2732 2005 8 Mayer GL and Sugaya T Fats of Life XX 4 12 2006 9 Nakamura T et al Am J Kidney Dis 47 439 444 2006 10 Kamijo Ikemori A et al Chn Chim Acta 374 1 7 2006 L_2. 2 2 8C 20 28C 3 4 5 1 1N 2 L_FABP 3 4
3. L FABP 2 5 ng mL 450nm 200 2 497 2 100 1 481 a 50 0 842 25 0 423 1 125 0 226 0 5 6 25 0 122 3 125 0 072 0 1 10 100 1000 0 0019 L FABP STD ng mL LFABP 14kDa LFABP
4. 6 7 30 8 1 19 7mg dL 21 8mg dL 24 4mg dL 45mg mL
5. 125mg mL 2 24 LFABP 1 1 40 2000mL 2 L FABP L FABP 400ng mL 0ng mL 1 A1 HI A1 H1 0ng mL 50zL A1 L FABP 400ng mL 50zL 10 50 L B1 G1 G1 50 L 1 2 3 4 5 6 7 8 9 10 11 12
6. ELISA L L FABP L FABP L FABP 2 LFABP LFABP LFABP _ L FABP 2 L FABP x L FABP
7. 1 2 20 80C 2 28C 80C 1 2 200ng mL 3 L FABP 2 8C 4 5
8. 1 L FABP L FABP 1 L FABP ug gCr WV LFABP 1 p lt 0 0001 10006 p lt 0 0001 p lt 0 0001 p lt 0 0001 1000 6 100T 10F 1 i L FABP 21 9 50 0 96 7 100 0 0 01 1 IV 9 4 46 7 60 0 91 3 95 8
9. 5 SPECTRA Max 340PC 15 200ng mL LFABP ng mL 200 150 ioo 50 y 0 9095x 5 495 0 r 0 9934 n 68 LFABP 1 1 2 3 1N 4 1
10. 5 2 LFABP L FABP 100 L 3 LFABP 20x L LTFABP 4 20 L L FABP 5 L FABP 5 20 28C 55 6 L FABP 7 350 gL 3 350 L 3 8 100 zL 9 5 20 28C 25
11. lh No 1 LFABP 96 x1 L_FABP 2 12mL x1 3 12mLx1 4 12mLx1 L FABP 2 5 12mL x 1 3 3 55 6 50mL x 1 7 12mL x1 IN 8 Ong mL 25mLx1 9 L FABP 400ng mL 0 5mLx1 L FABP 1 96 1 2 2 L FABP
12. 10 7 3 11 100 zL 12 5 20 28C 25 13 100 L 14 30 450nm 610nm 15 L FABP L FABP a L FABP 0ng mL 50uL 50uL 50gL 5 1004L 204L 5 20 28C 55
13. 1 2 3 4 n 70 n 64 n 30 n 30 n 23 2 2 2 3 6 0 5 0 10 3 7 7 89 9 85 7 276 9 227 8 ug gCr p Steel 1 L FABP 1 1 1 5ng mL 1 0ng mL 0 1 2 L FABP 200ng mL 1 5 2 20 3 8 CV 15 4 1 LFABP L FABP 2 3 L FABP L FABP 2
14. 3 5 20 28C 25 3 100gL 5 20 28C 25 1004L 30 450nm 610nm Ong mL L FABP L FABP L FABP lg L FABP g gCr 1 412 L FABP 8 4g g gCr 2 LFABP 200ng mL 0ng mL
15. gt AOOOOOOOOOOOO BOOOOOOOOOOOO ng mD CIOOOOOOOOOOOO g m J DOOOOOOOOOOOO 125 ng mD EOOOOOOOOOOOO ili FOOOOOOOOOOOO a GOOOOOOOOOOOO 8 gt HOOOOOOOOOOOO 3 4 a 2 1 20 50zL 50 100 zL 3 2000mL 4 5 6 450nm 610nm 3 20 28C LTFABP 1 L FABP 2 50 L LFABP 50 7L
16. 2015 5 3 2014 7 2 L FABP TMB 226ADAMXO0027000 L L FABP 1 2 3 SU 20 28C
17. FABP 105 0023 1 1 1 TEL 03 6779 8017 11 Nakamura T et al Diabetologia 50 490 492 2007 12 Negishi K et al Kidney Int 72 348 358 2007 13 Yamamoto T et al J Am Soc Nephrol 18 2894 2902 2007 14 Portilla D et al Kidney Int 73 465 472 2008 15 Nakamura K et al Drug Metab Pharmacokinet 23 271 278 2008 16 Nakamura T et al SHOCK 31 454 459 2009 17 NoiriE et al Am J Physiol Renal Physiol 296 669 679 2009 18 Nielsen SE et al Diabetes Care 32 1684 1688 2009 19 McMahon BA and Murray PT Kidney Int 77 657 659 2010 20 Nielsen SE et al Diabetes Care 33 1320 1324 2010 1 1 1
Download Pdf Manuals
Related Search